ResearcherUniversity of CopenhagenNo recent work listed
Janine Terra Erler
Matched on ORCID iD 0000-0001-8675-6527; OpenAlex author ID A5039753115. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 20
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden. Last author DOI 10.3389/fonc.2023.1096499↗
- Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade. Last author DOI 10.1038/s41467-021-23731-7↗
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug effic… Co-author DOI 10.15252/emmm.201404827↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sebastian Rune Nielsen · 2 shared papers, 2021–2023 · strength 0.33
- Jan E. Strøbech · 2 shared papers, 2021–2023 · strength 0.33
- Jennifer P. Morton · 2 shared papers, 2015–2021 · strength 0.14
- Paper Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment wi… DOI 10.1038/s41467-021-23731-7↗
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Owen James Sansom · 2 shared papers, 2015–2021 · strength 0.14
- Paper Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment wi… DOI 10.1038/s41467-021-23731-7↗
- Paper Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abro… DOI 10.15252/emmm.201404827↗
- Chang‐Il Hwang · 1 shared paper, 2021 · strength 0.11
- Luís Arnes · 1 shared paper, 2021 · strength 0.11
- David Arthur Tuveson · 1 shared paper, 2021 · strength 0.11
- Thomas R. Jeffry Evans · 1 shared paper, 2015 · strength 0.04
- Colin William Steele · 1 shared paper, 2015 · strength 0.04
- Caroline J. Springer · 1 shared paper, 2015 · strength 0.04
- Peter J. Bailey · 1 shared paper, 2015 · strength 0.04
- Karin A. Oien · 1 shared paper, 2015 · strength 0.04
- Kurt I. Anderson · 1 shared paper, 2015 · strength 0.04
- Nigel Balfour Jamieson · 1 shared paper, 2015 · strength 0.04
- Colin J. McKay · 1 shared paper, 2015 · strength 0.04
- C. Ross Carter · 1 shared paper, 2015 · strength 0.04
- Bryan W Miller · 1 shared paper, 2015 · strength 0.04
- David Kuang-Fu Chang · 1 shared paper, 2015 · strength 0.04
- Paul Timpson · 1 shared paper, 2015 · strength 0.04
- Andrew Victor Biankin · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.